Cardiology

Myeloproliferative Neoplasms

Questions discussed in this category

When you send for molecular studies for polycythemia vera, what are the mutations that predict increased cardiovascular risk?

How do you use this information in clinical practice?

1 Answer available

Papers discussed in this category

Haematologica, 2010-07

Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders.

The American journal of medicine, 1997-01

Inapparent polycythemia vera: an unrecognized diagnosis.

Haematologica, 2019 Aug 14

Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.

Related Topics in Cardiology